Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche par promoteur : Eli Lilly and Company Ltd
Femme et Homme Max 99 ans
Eli Lilly and Company Ltd
MAJ Il y a 4 ans
The DURABLE Trial: Assessing the DURAbility of Basal vs. Lispro Mix 25 Insulin Efficacy The Durability of Twice-Daily Insulin Lispro Low Mixture Compared to Once-Daily Insulin Glargine when added to Existing Oral Therapy in Patients with Type 2 Diabetes and Inadequate Glycemic Control
Initiation Phase The primary objective of the 6-month initiation phase of this study of patients with type 2 diabetes with inadequate glycemic control is to test the hypothesis that addition of twiced...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Eli Lilly and Company Ltd
MAJ Il y a 4 ans
Complaints Associated with Use of the Prefilled Pen B When Used by Patients with Type 2 Diabetes on Twice-Daily Insulin Therapy
The primary objective is to collect complaint data on the Prefilled Pen B when used by persons with type 2 diabetes to self-administer insulin in take-home situations for 2 months. These data will co...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Eli Lilly and Company Ltd
MAJ Il y a 4 ans
A Phase 3, Open-Label, Parallel Group Treatment Concordance Study to Compare Insulin Use and Its Effect on Glycemic Control in Patients with Type 2 Diabetes Mellitus: Two Populations with Different Insulin Treatment Options
The primary objectives are to test the hypothesis that: For insulin-naïve patients whose type 2 diabetes is not optimally controlled by 2 or more oral antihyperglycemic medications (including patient...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Précédent
1
2